Introduction
Anaerobic bacteria constitute almost 95% of the indigenous flora of the alimentary tract.
Among these organisms several opportunistic pathogens have been described, which are mainly Gram-negative anaerobic rods of the family Bacteroidaceae (1) . These bacteria are also associated with the colonizing flora of the oral cavity, and are quite similar in terms of their physiological properties, requirement for heme and utilization of mainly amino acids and peptides as energy sources. Furthermore, disease caused by infection of anaerobic bacteria is an area of growing concern although little is known about the fundamental biology of many of these organisms (2) . Periodontal diseases result in gum tissue destruction and in some cases the spread of the infective anaerobic flora into the blood, which can cause soft tissue infections in the pulmonary tract, brain abscesses and heart disease (3).
Porphyromonas gingivalis, one of the main causes of such infections, is an obligate anaerobe whose colonies are recognised by their characteristic heme pigments on blood agar plates (1) .
Heme is central to metabolism in nearly all organisms, especially in its role as a prosthetic group involved in electron transport. Its synthesis occurs via a branched biosynthetic pathway, which is also responsible for the synthesis of other modified tetrapyrroles including cobalamin (vitamin B 12 ) (Figure 1 ) (4). P. gingivalis exhibits an absolute growth requirement for heme in vitro (5) although it is not known whether this exogenous heme is used to complement an inability of the organism to make its own heme or whether, for instance, the exogenous heme is being used as a source of iron. Similarly, recent evidence also indicates that P. gingivalis requires adenosylcobalamin as a prosthetic group (6) but again it is not known whether the bacterium is able to make its own cobalamin. The biologically active forms of vitamin B 12 , methyl and adenosylcobalamin, are required in methylation and by guest on November 6, 2017 http://www.jbc.org/ Downloaded from rearrangement reactions respectively (7) . The biosynthesis of cobalamin represents one of the most complex pathways in Nature, involving somewhere around thirty enzyme-catalyzed reactions. These include the genes encoding enzymes responsible for the synthesis of uroporphyrinogen III, the first macrocyclic intermediate in tetrapyrrole synthesis, the genes encoding enzymes for the transformation of uroporphyrinogen III into cobinamide and the genes encoding enzymes for nucleotide loop assembly and attachment to the corrin ring (8) (9) (10) (11) . The steps required for the synthesis of cobalamin are highlighted in figure 2.
Studies over the past decade have demonstrated that there are at least two quite distinct routes for cobalamin synthesis, representing oxygen-dependent (aerobic) and oxygen-independent (anaerobic) pathways (12) (13) . For the biosynthesis of cobinamide, the genes of the oxygendependent route are prefixed cob whilst the genes for the oxygen-independent pathway are prefixed cbi (Figure 2) 1 . The major differences between the two pathways relate to the requirement for molecular oxygen and the timing of cobalt insertion: in the oxygen-dependent pathway molecular oxygen is required to assist in the ring contraction process and cobalt is added relatively late on in the pathway, only after the synthesis of hydrogenobyrinic acid a,cdiamide whilst in the oxygen-independent pathway molecular oxygen is not required and cobalt is inserted into the macrocycle at an early stage of the synthesis, at the level of precorrin-2 ( Figure 2 ).
In this paper, investigations into the ability of P. gingivalis to make tetrapyrroles, and in particular cobalamin, are reported. Although the organism appears to contain a functional oxygen-independent corrin biosynthetic pathway, which is able to transform precorrin-2 into cobalamin, the presence of the pathway is compounded by the lack of any enzymes for the synthesis of precorrin-2.
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Experimental procedures.
Horse blood was bought from Difco (Detroit, Michigan, USA), and other media components were purchased from Oxoid (Basingstoke, Hampshire, UK). The RapID ANA II diagnostic system was from Innovative Diagnostic systems (Norcross, GA, USA). Perchloric acid was purchased from Aldrich Chemicals (Gillingham, Dorset, UK) while other chemicals were from Sigma chemicals (Poole, Dorset, UK). All general nucleic acid protocols were carried out as described in (14) . Protein was quantitated according to the Bradford procedure (15).
Cobyric acid was synthesized as described by Bonnett et al. (16) .
Bacterial Growth
All strains and plasmids are shown in ALAD activity was determined by the amount of porphobilinogen (PBG) formed using a stopped spectrophotometric assay. The method was essentially as described previously (18) except that 5-aminolevulinic acid (ALA) (5 mM final concentration) was preincubated for 2 min in assay buffer at 37 o C and the reaction started by the addition of bacterial extracts (up to 2 mg protein), to give a final volume of 0.5 ml.
Porphobilinogen deaminase (PBGD) assay.
PBGD activity was measured according to the method described by Jordan et al (19) . Briefly, crude cell extract (500 µl) was incubated at 37˚C in a final volume of 800 µl, containing 100 mM Tris/HCl buffer, pH 8.0. The reaction was started by the addition of 0.1 µmoles of porphobilinogen (PBG). The reaction was stopped after either 30 or 60 min by the addition of 0.2 ml of 5 N HCL. Ten microlitres of freshly prepared benzoquinone (1 mg/ml) was added to the solution. The mixture was centrifuged and after 15 min the solution was measured at 405 nm to quantify the amount of uroporphyrin formed, using an extinction coefficient of 5.48 x 10 5 M -1 cm -1 .
CbiK assay
The activity of the long and short version of CbiK, CbiK L and CbiK S respectively, was determined using an in vitro linked assay, similar to that described in (20 
Cobalamin Bioassay
Cobalamin concentrations were determined using a modified bioassay. Bioassay plates were prepared as described previously (21) Where possible bacteria that were to be tested for the presence of cobalamin were grown in defined medium (17) . However, not all strains were amenable to growth in defined medium and had to be grown on columbia blood agar plates. In this case the background level of cobalamins available from the media had to be taken into account and the results were based on the conversion of exogenously added cobyric acid (100 nmol/plate or 1000 nmol/plate) to cobinamide.
PCR
Whole genomic DNA from P. gingivalis W83 was used as a template for initial isolation of porphinoid genes by PCR. Degenerate PCR was used to amplify a partial gene sequence of 365 bp encoding a fragment of cbiP. Degenerate PCR primers were designed from a highly conserved region of cbiP from known bacterial sequences (between amino acids 59 and 174 of S. typhimurium cbiP), using CODEHOP (consensus-degenerate hybrid oligonucleotide primers for amplification of distantly-related sequences) (22) . Degenerate primers to two other genes, hemB (encoding ALAD) and btuR (encoding the adenosyl transferase) were also designed ( Table 2 ) but although these worked on control samples of DNA (S. typhimurium genomic DNA) they failed to amplify a product with genomic DNA from P. gingivalis.
Primers designed to known DNA sequence were used to isolate cbiGF, cbiJD, cbiL and cbiK ( City, California, USA) to confirm the identities and sequence of the isolated genes.
Subcloning the cbi genes for expression studies
Cloning procedures were performed as described in (14) . The isolated cobalamin biosynthetic genes from P. gingivalis including cbiL, cbiK, cbiGF and cbiJD were separately cloned into pKK223-3 under the regulation of a tac promoter by directional cloning. A second set of plasmids were also constructed whereby each gene or gene fusion was cloned into pET14b behind a His-tag encoding sequence, under the control of a T7 promoter.
The pKK constructs were used to carry out functional complementation tests on either defined S. typhimurium or recombinant E. coli cobalamin mutants. The pET constructs were used for expression of protein for affinity purification by metal chelate chromatography. The plasmids and strains are described in Table 1 .
Purification of His-tagged proteins.
The protein was expressed and purified as described in the pET manual (Novagen). Briefly, a culture of the appropriate strain was grown in LB containing ampicillin and chloramphenicol column which had been previously equilibrated in 50 mM Tris-HCl, pH 7.8.
Databases & Computer Programs
Sequences, alignments and comparisons were performed with the GCG Wisconsin Package.
Searches of the Unfinished Bacterial Genome Database were performed using the Blast suite (http://www.ncbi.nlm.nih.gov/blast/unfinsihedgenome.html). Evolutionary trees were constructed using PAUP 4.0.
Results.
Since the gene for methylmalonyl CoA mutase, a B 12 -dependent enzyme, had previously been isolated and sequenced from P. gingivalis (6) , it was decided to investigate whether the bacterium was able to synthesize the coenzyme required for this reaction (adenosylcobalamin)
de novo, by determining the presence of any cobalamin biosynthetic genes.
This was achieved using a degenerate PCR approach with primers designed to btuR (11), the cobalamin adenosylation enzyme, and CbiP, cobyric acid synthase (see Figure 2 ). Degenerate PCR with the btuR primers did not produce any DNA products of the correct size, although a negative result by this procedure does not mean the gene is absent since the process is reliant on a high degree of similarity with gene homologues. However, the lack of success with these primers may also be explained by the fact that not all bacteria capable of de novo cobalamin (Figures 2 and 3 ). These 14 genes encode for enzymes that perform 17 different enzymatic transformations. The discrepancy between the number of genes and the number of enzymatic transformations is due to the fact that three of the genes encode for bifunctional proteins, where two separate genes would appear to have fused together (cbiJD, cbiET and cbiGF). Of the 14 genes, 11 appear to be clustered into 3 operons whilst the remaining three genes are dispersed randomly throughout the genome (Figure 3 ).
GF, -JD, -B, -P, -A, cobD, -S, -T, -U)
The identified genes appear to encode mainly for the enzymes that are responsible for the transformation of precorrin-2 into cobalamin ( Figure 2 ). An alignment of the cobalamin biosynthetic methyltransferases found in the P. gingivalis genome (CbiL, -H, -J, -ET, -GF) with all other known cobalamin biosynthetic methyltransferases allowed a phylogenetic tree to be produced (data not shown) (23) . Not surprisingly, the P. gingivalis methyltransferases segregated with enzymes associated with the oxygen-independent pathway. Indeed, three of the other cobalamin genes, cbiD, cbiG and cbiK can also be considered the genetic hallmarks of the anaerobic pathway, since they are only found in organisms that contain the oxygenindependent route (13).
Of significant interest was the absence of gene homologues that encode for any of the enzymes of precorrin-2 synthesis. Furthermore, degenerate primers to 5-aminolevulinic acid dehydratase (ALAD) failed to amplify any product and enzymatic assays on crude cell extracts from P. givgivalis for ALAD and porphobiliogen deaminase (PBGD) failed to demonstrate any enzymatic activity. As for other modified tetrapyrrole synthesis, the only genes that were recorded in the genome were a few for heme synthesis including hemN, encoding an anaerobic coproporphyrinogen oxidase, and hemH which encodes the protoporphyrin ferrochelatase. Thus the P. gingivalis genome would appear to harbor all the cbi genes together with a few late heme biosynthetic genes, but none of the genes for the synthesis of ALA and its transformation into precorrin-2.
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Cloning and functional complementation.
Although the P. gingivalis cbi genes appear to contain the genetic hallmarks of the oxygenindependent corrin pathway, there were a number of gene fusions that had not been observed previously. For instance, cbiJ and cbiD appeared fused together as did cbiG and cbiF.
Moreover, P. gingivalis also appeared to harbor cbiK, a gene now known to encode the anaerobic cobalt chelatase (24, 25) and which has been detected in only four other organisms,
S. typhimurium, Clostridium difficile, Clostridium acetobutylicum and Clostridium tepidum.
To evaluate the functionality of some of these genes, they were cloned and used in a series of complementation experiments (see below and Table 3 ).
The genes cbiL, cbiJD, cbiK, cbiGF and cbiK were amplified from P. gingivalis genomic DNA and cloned into pKK223-3 and were then used to complement either defined S.
typhimurium, E. coli or recombinant E. coli cobalamin biosynthetic mutants. With cbiK there was a certain ambiguity with the size of the protein since the gene had two potential translation start codons, the first of which appeared to give the protein an 18-28 amino acid extension at the N-terminus in comparison to other CbiK proteins. A motif search in the PROSITE dictionary of protein sites and patterns indicated that this extension displays some of the features associated with signal peptides found on membrane lipoproteins (26) .
Intriguingly, CbiK is the subject to two independent patent applications in Australia, with the authors citing CbiK as an immuno-reactive antigen 3 , supporting a theory that the protein is exported to the outer membrane. This is sustained by results detailing how CbiK is able to act as an outer membrane heme-binding protein that is important for the growth of P. gingivalis (27, 28) . There is a suggestion that CbiK may be associated with a protective immune response against P. gingivalis-induced periodontitis (27) .
To test whether the P. gingivalis CbiK was active in the cobalamin biosynthetic pathway, cbiK was cloned such that it was expressed from the first methionine and was referred to as CbiK-long, CbiK L . Initially the cloned cbiK L was used to complement an E. coli cysG 4 mutant after the gene had been cloned in tandem with a uroporphyrinogen III methyltransferase from P. denitrificans (cobA). The plasmid was found to complement efficiently the cysG deficiency of the strain, indicating that cbiK L was functional as a precorrin-2 ferrochelatase in siroheme synthesis. However, the addition of exogenous cobalt to the medium prevented this complementation suggesting that the ferrochelatase activity is inhibited by cobalt, consistent with the function of CbiK being a cobalt chelatase (24, 25) . If CbiK L does contain a signal peptide, it would not appear to be transported since in E. coli, at least, CbiK L would appear to be retained in the cytosol.
When the P. gingivalis cbiK L was used to complement a cobalt chelatase deficient E. coli corrin producing strain, the gene was found to restore cobalamin levels to those previously observed with the S. typhimurium cbiK (Table 3 ) (24) . Thus, the P. gingivalis and S.
typhimurium cbiK are functionally equivalent encoding precorrin-2 cobalt chelatases that can also act as precorrin-2 ferrocehlatases. Moreover, the P. gingivalis protein can be modeled accurately onto the S. typhimurium CbiK structure (25) , with complete conservation of the amino acids involved in catalysis and structure formation (Figure 4) . To investigate the role of the N-terminal extension, cbiK was expressed in both long (CbiK L ) and short (CbiK S )
versions as N-terminally His-tagged recombinant proteins in E. coli. This was achieved by cloning the respective genetic transcripts into pET14b. The two proteins were purified by metal chelate chromatography. Interestingly, the protein with the potential membrane lipoprotein signal sequence did not purify as easily as the protein without the signal and displayed a tendency to aggregate ( Figure 5 ). The two proteins were used for in vitro assays, which demonstrated that they both catalyzed the insertion of Co 2+ into precorrin-2 with similar efficiency (Figure 6 ).
When cbiL, which encodes a cobalt-precorrin-2 methyltransferase (29), was cloned into pKK223-3, the resultant plasmid was found to complement a S. typhimurium cbiL strain (Table 3 ) (11, 21) . In this respect the S. typhimurium and P. gingivalis cbiL are interchangeable. The two bifunctional genes, cbiJD and cbiGF (encoding multifunctional enzymes of unknown function) were also cloned into pKK223-3. However, the presence of the P. gingivalis cbiJD did not restore cobalamin synthesis to a S. typhimurium cbiD strain.
This result is consistent with the appearance of at least two classes of cbiD, reflecting some subtle differences in the anaerobic cobalamin pathway. For instance, the B. megaterium cbiD does not efficiently complement the S. typhimurium cbiD strain (11) . The ability of the fusion protein to complement a cbiJ mutant was not tested.
The P. gingivalis cbiGF was found to complement a S. typhimurium cbiF mutant (11) indicating that the encoded protein is functional, in part, as the C-11 methyltransferase. The
CbiF region of the fusion protein also modeled well onto the previously determined CbiF structure (30) , in agreement with its functionality (data not shown).
The cbiGF fusion was not tested for its ability to complement defined cbiG mutants. The functional complementation experiments demonstrate that the P. gingivalis genes represent part of an oxygen-independent pathway, broadly similar to those described for S. typhimurium and B. megaterium ( Figure 2) (8, 13).
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Properties of the expressed proteins.
As with CbiK (cobalt cheltase), the other proteins, CbiL (C-20 methyltransferase), CbiJD (unknown function) and CbiGF (unknown function), were overproduced as recombinant Histagged variants in E. coli. This was accomplished by cloning the respective genes into pET14b, which after transformation into BL21/pLysS allowed the recombinant proteins to be expressed to a level of at least 10% of total cellular protein. CbiK, CbiL and CbiGF were all found to be largely soluble whilst CbiJD was found to be largely insoluble. However, CbiJD could be resolubilised in 6M GnHCL and, after dialysis, remained in solution. The proteins could all be purified by metal affinity chromatography and the purified proteins are shown in The overproduced proteins are currently being used for in vitro assays and in attempts to crystallize the proteins.
Can P. gingivalis make cobalamin de novo?
The absence of any genes for the synthesis of precorrin-2 suggested that the bacterium was incapable of de novo synthesis of cobalamin. To address this possibility, cells were grown on a range of complex and defined media in order to ascertain whether there was any evidence for de novo synthesis of cobalamin.
When grown on rich medium (CBA), known to contain exogenous vitamin B 12 , P. gingivalis strain W83 accumulated cobalamin to a level of ~ 5 pmol/10 9 cells (Table 4 ). The bacteria were subcultured on defined medium (17) in the absence of vitamin B 12 , on which it was noted that the levels of cobalamin dropped to ~1pmol/10 9 cells (Table 4) other bacteria, and which have been reported in P. gingivalis (31) . On all this available evidence it would appear that P. gingivalis is unable to synthesize its own cobalamin and relies on uptake to meet its coenzyme requirement.
Since the bacteria harbor genes capable of converting precorrin-2 into cobalamin, precorrin-2 was added to liquid cultures of P. gingivalis growing in defined media. This did not result in any increase in endogenous cobalamin synthesis, merely suggesting that precorrin-2 is probably not taken up by the cells. Indeed, the first cobalamin pathway intermediate known to be taken up in other bacteria is cobyric acid. When this compound was added to the defined P. gingivalis medium, not surprisingly, it was found that it was converted into cobalamin (or at least an intermediate between cobinamide and adenosylcobalamin) ( Table 4 ). This was deduced from the observed growth of a S. typhimurium indicator strain, AR2680, induced by extracts of P. gingivalis that had been supplemented with cobyric acid. The indicator strain cannot convert cobyric acid into cobinamide and hence cannot make cobalamin due to a mutation within cbiB. Growth of the indicator strain is therefore dependent upon the presence of exogenous cobinamide (or a later pathway intermediate). The conversion of cobyric acid into cobinamide (and later intermediates) in P. gingivalis was, as expected, dependent upon the concentration of added exogenous cobyric acid i.e. the transformation of cobyric acid was dose dependent (Table 4 ). This result demonstrated that, at least, the cobD (encoding L-threonine-phosphate decarboxylase) and cbiB (encoding cobinamide synthase) (9) gene products must be functionally active.
To test whether the presence of this cobalamin pathway was an isolated phenomenon of W83, we investigated the ability of a large number of other related strains to convert cobyric acid into cobinamide. To this end, several P. gingivalis strains were tested, along with closely related Bacteroides and Prevotella species. These species were selected so that a broad range of pigmented and non-pigmented species, which are often found in the same habitat, could be tested. All but Pr. loescheii were able to convert exogenously supplied cobyric acid into cobinamide (Table 5 ). Pr. loescheii was capable of taking up exogenously supplied cobyric acid but did not convert it to cobinamide.
Discussion.
The ability of P. gingivalis to biosynthesize tetrapyrroles de novo has been investigated.
Extracts of the bacterium do not possess activity for ALAD or PBGD, two key enzymes involved in the synthesis of uroporphyrinogen III. Similarly, it was not possible to detect any genetic evidence for these early enzymes with the use of degenerate PCR or by searching the data bases of the P. gingivalis genome sequencing project. However, biochemical and genetic investigations demonstrated that the bacterium did harbor the genes for the conversion of precorrin-2 into cobinamide. Some of these genes appeared as fusions, including cbiJD and cbiGF, and these can be interpreted with respect to the previously unidentified functions for
CbiD and CbiG, since other fusion proteins in the cobalamin biosynthetic pathway appear to occur between enzymes that catalyze consecutive steps. For example, CbiET, which is also equivalent to CobL in the oxygen-dependent pathway, catalyses the methylation at C5/15 as well as the decarboxylation step in corrin synthesis (32) , whilst CbiKL catalyses the cobalt insertion step and methylation at C-20 (http://www.sanger.ac.uk/Projects/C_difficile/). On this basis it is likely that CbiG would catalyze a step prior to C-11 methylation, possibly the delta-lactone formation that gives rise to cobalt precorrin-4 ( Figure 2 ) (33) . Similarly, CbiD would therefore be likely to catalyze a step prior to corrin ring reduction, presumably the removal of the C-2 fragment and methylation processes at C-1 ( Figure 2 ) (13, 32, 33) .
Why an incomplete cobalamin biosynthetic pathway?
The research we have described on P. gingivalis reveals a number of interesting facts that are difficult to reconcile. First of all, there is no evidence that the bacterium can make uroporphyrinogen III, the universal macrocyclic primogenitor of heme, chlorophyll, siroheme and cobalamin (4) . On this basis one would assume that the bacterium was unable to make any modified tetrapyrrole de novo, consistent with observations that exogenous heme and by guest on November 6, 2017
http://www.jbc.org/ Downloaded from cobalamin are required for growth. Secondly, following on from this point, it was somewhat surprising to discover that P. gingivalis contained a corrin pathway, with all the necessary enzymes to convert precorrin-2 into cobalamin. Some of these enzymes were shown to complement defined S. typhimurium and E. coli cobalamin biosynthetic mutants. P. gingivalis is able to take up exogenously added cobyric acid and convert it into cobalamin, indicating that at least some of these enzymes are expressed within the cell. Why then does the bacterium contain a functional corrin pathway if it is unable to make the precorrin-2 substrate for entry into the pathway? The least likely explanation is that the bacterium may have evolved a completely different method for the synthesis of precorrin-2. The recent discovery that precorrin-2 can be converted into heme demonstrates that there is still much to be learnt about tetrapyrrole metabolism (34) . Moreover, it is known that there are two routes for ALA synthesis (4), therefore alternative routes for the synthesis of uroporphyrinogen III/precorrin-2 may also exist. However, the fact that we were unable to detect any de novo synthesis of cobalamin in P. gingivalis suggests that such an alternative pathway does not exist in this organism. It would be unlikely that the bacterium is able to convert heme back into precorrin-2 for thermodynamic reasons, since the porphyrin macrocycle would have to be reduced back to the level of a hexahydroporphyrin and have its side chains modified to those observed in uroporphyrinogen III. Furthermore, all the P. gingivalis cultures were grown on medium containing exogenous heme, yet there was no evidence that any endogenous cobalamin was being produced.
A more likely explanation is that the bacterium has only relatively recently lost its early heme biosynthetic operon but has not yet lost its remaining cbi genes. There is no evidence that any of these cbi genes have become inactive indicating little time has elapsed for gene alterations to have taken place, although there is some evidence to suggest that CbiK may have evolved a new role in heme binding (27, 28) . Indeed, the structure of CbiK is very similar to that of protoporphyrin ferrochelatase (30) and may well be able to bind protoheme when complexed with other proteins.
Moreover, the bacterium would appear to have lost most of its heme biosynthetic genes, since there is no hemD, E or G. The remaining hemH may be retained to act as a dechelatase to aid in the removal of iron from exogenously imported heme, as has been suggested in Haemophilus influenza (35) . The presence of the putative coproporphyrinogen oxidase, HemN, may be misleading since its function is not yet fully understood. As a pathogen living on a rich medium, P. gingivalis would appear to have lost its selection pressure in keeping the ability to make tetrapyrroles de novo. The bacterium has evolved efficient transport systems to import exogenous heme and cobalamin. The presence of the cobinamide biosynthetic enzymes in P. gingivalis means that the bacterium can salvage the corrin component of cobalamin, and convert it back into the coenzyme form. A similar situation also exists in E.
coli, where the organism has maintained its nucleotide assembly and attachment genes but has lost the genes responsible for the biosynthesis of cobinamide (36, 37).
In conclusion, P. gingivalis does not appear to have the ability to make either heme or cobalamin de novo. Both modified tetrapyrroles are somehow accumulated from the growth medium. A summary of the remaining pieces of the biosynthetic pathway in P. gingivalis is shown in figure 7 . Footnotes:
1. The nomenclature relating to the cobalamin biosynthetic genes is confusing. In the aerobic pathway all genes for the conversion of uroporphyrinogen III into cobalamin are prefixed cob, whilst in the anaerobic route the genes for the conversion of precorrin-2 into adenosylcobinamide phosphate are prefixed cbi with the genes for the nucleotide loop assembly prefixed cob. Thus the cobA gene refers to two quite distinct enzymes depending whether reference is being made to the aerobic or anaerobic pathway. In the absence of CbiK, a spectrum of partially-oxidised precorrin-2 was obtained (broad absorption maximum between 380-400 nm) since the reaction was performed under aerobic conditions. In the presence of either CbiK L or CbiK S , the spectrum of cobalt sirohydrochlorin was obtained, consistent with the function of CbiK as a cobalt chelatase. Table 2 Gene 
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